Amanta Healthcare Limited (AMANTA) Q2 FY27 Financial Results: PAT ₹476.35 Cr & Revenue ₹6,944.62 Cr

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
MetricValue
Revenue₹6,944.62 Cr
Net Profit (PAT)₹476.35 Cr
📢 Key Event
Amanta Healthcare Limited publishes unaudited Q1 FY2026 financial results in newspapers and on website
🔄 What Changed
Standalone net profit after tax rose to ₹476.35 crores; consolidated net profit after tax reached ₹2,350.27 crores; exceptional gain of ₹96.02 lakh recognized
💡 Investor Takeaway
The company reported strong consolidated profitability with notable growth in net profit and income, supported by regulatory compliance and exceptional gains.

Amanta Healthcare Limited (AMANTA) announced on August 7, 2026, the publication of its unaudited financial results for the quarter ended June 30, 2026, in newspapers and on its website, complying with SEBI Listing Regulations. The filing includes standalone total income of ₹1,148.66 crores and consolidated total income of ₹3,305.85 crores, with standalone net profit after tax at ₹476.35 crores and consolidated net profit after tax at ₹2,350.27 crores. The Board approved these results on August 5, 2026, following review by the Audit Committee. Key disclosures include an exceptional gain of ₹96.02 lakh from loss of control and adjustments related to GST demands and legal matters. Shareholding changes and equity details were also updated.

📄 View Original Announcement (PDF)

About Amanta Healthcare Limited (AMANTA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹726.89 Cr P/E: 45.0 ROE: 15.2% ROCE: 14.1%

View full AMANTA stock details →

📡 Get AI alerts when AMANTA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMANTA — Free

📊 More AMANTA filings

See all AMANTA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMANTA files new disclosures

Track AMANTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMANTA — Free

Free account · 2 AI queries/day